A Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of 2 Dosage Strengths of E2006 on a Multiple Sleep Latency Test in Subjects With Insomnia Disorder

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of 2 Dosage Strengths of E2006 on a Multiple Sleep Latency Test in Subjects With Insomnia Disorder

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Lemborexant (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 29 May 2015 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
    • 03 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top